Cardurion Pharmaceuticals
Translating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics
80 employees · est. 2017 · Burlington, United States
Myogen
Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.
est. 1996
Myogen is the older company (2017 vs 1996).
Side-by-Side Comparison
| Metric | Cardurion Pharmaceuticals | Myogen |
|---|---|---|
| Founded | ||
| Founded | 2017 | 1996 older |
| Headquarters | ||
| Headquarters | Burlington, United States | Not tracked yet |
| Employees | ||
| Employees | 80 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Series D |
| Total Funding | ||
| Total Funding | $603.20M | $187.77M |
| Funding Rounds | ||
| Funding Rounds | 5 | 5 |
| Services | ||
| Services | Research and Development of Cardiovascular Drugs, Clinical Programs in PDE9 and CaMKII, In-house Drug Discovery, Clinical Study Evaluation | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Cardiovascular Disease, Healthcare Providers, Pharmaceutical Companies, Biotechnology Investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cardurion Pharmaceuticals, Cardiac Myocyte Signaling Pathways, PDE9 Inhibition, CaMKII Inhibition, Cardiovascular Therapeutics, Heart Failure Treatment, Biotechnology Company, Clinical Programs, Cardiovascular Diseases, Partnerships, Investors, Bain Capital, Takeda Pharmaceutical, Astellas, Drug Discovery, Boston-based Company | Biopharmaceutical Company, Cardiovascular Health, Small Molecule Therapeutics, Discovery, Development, Commercialization, Clinical Expertise, Cardiovascular Disorders, Biology Of Cardiovascular Disease, Clinical Development Expertise, Novel Therapies, Licensing, Acquisition, Unmet Medical Needs |
| Website | ||
| Website | cardurion.com | myogen.com |
About Cardurion Pharmaceuticals
Cardurion Pharmaceuticals, founded in 2017, is a biotechnology and pharmaceutical company targeting advancements in cardiovascular health through innovative drug discovery. The company is renowned for its expertise in translating cardiac myocyte signaling pathways into groundbreaking therapeutics, s...
About Myogen
Myogen is a biopharmaceutical company founded in 1996, dedicated to advancing cardiovascular health with innovative small molecule therapeutics. Their slogan "Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs" reflects their mission. The company focu...
We will tell you when either one moves
BounceWatch watches Cardurion Pharmaceuticals and Myogen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cardurion Pharmaceutic... and Myogen — by email.
Frequently Asked Questions
Compare Cardurion Pharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cardurion Pharmaceuticals on 12 Sep 2024, and Myogen on 26 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.